Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study.

Circulation

From Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, National Heart and Lung Institute, Biomedical Research Unit, Royal Brompton Hospital, Imperial College, London, UK (A.K., W.L., G.-P.D., K.D., S.T.W., M.A.G.); Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (C.S.H., A.S.J., L.S.); Beijing Anzhen Hospital, Capital Medical University, China (G.H.); Boston Adult Congenital Heart and Pulmonary Hypertension Service, Boston Children's Hospital and Brigham and Women's Hospital, Harvard Medical School, MA (A.R.O., M.J.L.); Department of Cardiology, University Hospitals Leuven, Belgium (W.B.); Department of Cardiology, Academic Medical Center, Amsterdam, Netherlands (B.J.M., I.B.); Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland (L.T.-P.); AGH University of Science and Technology, Cracow, Poland (K.S.); Department of Cardiology, Second University of Naples, Italy (M.D'A., G.S.); Adult Congenital Heart Centre, University Medical Center, Ljubljana, Slovenia (K.P.); Department of Cardiology, Rikshospitalet Oslo University Hospital, Norway (M.-E.E.); and Department of Cardiology, Lund University Hospital, Sweden (U.T.).

Published: April 2017

Background: Eisenmenger syndrome is associated with substantial morbidity and mortality. There is no consensus, however, on mortality risk stratification. We aimed to investigate survival and predictors of death in a large, contemporary cohort of Eisenmenger syndrome patients.

Methods: In a multicenter approach, we identified adults with Eisenmenger syndrome under follow-up between 2000 and 2015. We examined survival and its association with clinical, electrocardiographic, echocardiographic, and laboratory parameters.

Results: We studied 1098 patients (median age, 34.4 years; range, 16.1-84.4 years; 65.1% female; 31.9% with Down syndrome). The majority had a posttricuspid defect (n=643, 58.6%), followed by patients with a complex (n=315, 28.7%) and pretricuspid lesion (n=140, 12.7%). Over a median follow-up of 3.1 years (interquartile range, 1.4-5.9), allowing for 4361.6 patient-years observation, 278 patients died and 6 underwent transplantation. Twelve parameters emerged as significant predictors of death on univariable analysis. On multivariable Cox regression analysis, only age (hazard ratio [HR], 1.41/10 years; 95% confidence interval [CI], 1.24-1.59; <0.001), pretricuspid shunt (HR, 1.56; 95% CI, 1.02-2.39; =0.041), oxygen saturation at rest (HR, 0.53/10%; 95% CI, 0.43-0.65; <0.001), presence of sinus rhythm (HR, 0.53; 95% CI, 0.32-0.88; =0.013), and presence of pericardial effusion (HR, 2.41; 95% CI, 1.59-3.66; <0.001) remained significant predictors of death.

Conclusions: There is significant premature mortality among contemporary adults with Eisenmenger syndrome. We report, herewith, a multivariable mortality risk stratification model based on 5 simple, noninvasive predictors of death in this population.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.023033DOI Listing

Publication Analysis

Top Keywords

eisenmenger syndrome
16
predictors death
12
syndrome
5
death contemporary
4
contemporary adult
4
patients
4
adult patients
4
eisenmenger
4
patients eisenmenger
4
syndrome multicenter
4

Similar Publications

Adult aortopulmonary window is a rare presentation of a rare disease; only a few cases are reported to have undergone successful surgical closure without development of Eisenmenger syndrome. We describe the second oldest patient, a 25-year-old woman, who underwent successful surgical repair of aortopulmonary window after favorable indirect measures on echocardiography without the "gold standard" preoperative cardiac catheterization study. At 2 months after the operation, the patient remains in New York Heart Association class II.

View Article and Find Full Text PDF

This case report presents a 37-year-old male with a complex medical history, including HIV, chronic methamphetamine and cocaine use, and an atrial septal defect, who developed severe pulmonary arterial hypertension (PAH), biventricular failure, and recurrent stroke. The patient was admitted with acute neurological deficits and respiratory failure, which rapidly progressed despite intensive management. Laboratory and imaging studies revealed severe cardiac dysfunction and elevated pulmonary vascular resistance.

View Article and Find Full Text PDF

The aim of this single-centre retrospective observational study was to evaluate the safety, tolerability, and efficacy of an in-class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension. Children aged over 5 years who were established on sildenafil plus bosentan were offered to undergo a therapy switch from May 2014 to May 2021 and, if remaining in the service, followed up to May 2024. Children with Eisenmenger syndrome, open intra or extra-cardiac shunt, or with pulmonary hypertension-associated lung disease were excluded.

View Article and Find Full Text PDF

Eisenmenger syndrome during pregnancy: A true anesthetic challenge.

Med J Armed Forces India

December 2024

Professor & Senior Advisor, (Anaesthesia & Critical Care), Command Hospital (Eastern Command), Kolkata, West Bengal, India.

Eisenmenger syndrome (ES) is a rare congenital heart disease (CHD) that occurs in persons with large intracardiac anatomical defects which may go undetected for many years, consequently results in reduced life expectancies and high mortality in the third and fourth decade of life. Pregnancy in patients with CHD and pulmonary arterial hypertension (PAH) is presaged with challenges, and perioperative management of such cases remains a topic of debate. Our case had both, atypical presentation, not diagnosed until her third trimester of third pregnancy and a quick progression to a severe stage with PAH and CorPulmonale.

View Article and Find Full Text PDF

Ebstein's anomaly is a rare congenital displacement of the tricuspid valve resulting in atrialization of the right ventricle. About half of the patients with Ebstein's anomaly also have atrial septal defects, which may lead to chronic shunting and development of Eisenmenger syndrome. We describe a case of a sexagenarian male patient with a history of Ebstein's anomaly complicated with Eisenmenger syndrome undergoing robotic laparoscopic adrenalectomy who presented hemodynamic instability, hypoxemia, and likely right-to-left shunting intraoperatively, as well as the actions taken to correct it and have a successful outcome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!